Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium

Headache

Volumn 54, Issue 2, 2014, Pages 313-324

  Gallelli, Luca ^a   Avenoso, Tiziana ^a   Falcone, Daniela ^a   Palleria, Caterina ^a   Peltrone, Francesco ^b   Esposito, Maria ^c   De Sarro, Giovambattista ^a   Carotenuto, Marco ^c   Guidetti, Vincenzo ^a,d  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b PUGLIESE CIACCIO HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

acetaminophen; children; ibuprofen; magnesium; migraine; visual analog scale

Indexed keywords

ACETAMINOPHEN; CHILDREN; IBUPROFEN; MAGNESIUM; MIGRAINE; VISUAL ANALOG SCALE;

ACETAMINOPHEN; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IBUPROFEN; MAGNESIUM; MALE; MIGRAINE DISORDERS; PAIN MEASUREMENT; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893923593     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12162     Document Type: Article

References (50)

1. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S, American Academy of Neurology Quality Standards Subcommittee, Practice Committee of the Child Neurology Society. Practice parameter: Pharmacological treatment of migraine headache in children and adolescents: Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004; 63: 2215-2224.
2. Esposito M, Pascotto A, Gallai B, et al. Can headache impair intellectual abilities in children? An observational study. Neuropsychiatr Dis Treat. 2012; 8: 509-513.
3. Seshia SS, Wang SJ, Abu-Arafeh I, et al. Chronic daily headache in children and adolescents: A multi-faceted syndrome. Can J Neurol Sci. 2010; 37: 769-778.
4. Kernick D, Campbell J,. Measuring the impact of headache in children: A critical review of the literature. Cephalalgia. 2008; 29: 3-16.
5. Lateef TM, Merikangas KR, He J, et al. Headache in a national sample of American children: Prevalence and comorbidity. J Child Neurol. 2009; 24: 536-543.
6. Termine C, Ferri M, Balottin U,. Acute treatment of migraine in children and adolescents. Funct Neurol. 2008; 23: 63-69.
7. Usai S, Grazzi L, Andrasik F, Bussone G,. An innovative approach for migraine prevention in young age: A preliminary study. Neurol Sci. 2010; 31: S181-S183.
8. Kabbouche MA, Cleves C,. Evaluation and management of children and adolescents presenting with an acute setting. Semin Pediatr Neurol. 2010; 17: 105-108.
9. Gallelli L, Iannacchero R, De Caro E, Peltrone F, Colosimo M, De Sarro G,. A questionnaire-based study on prevalence and treatment of headache in young children. J Headache Pain. 2005; 6: 277-280.
10. Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW,. Symptomatic treatment of migraine in children: A systematic review of medication trials. Pediatrics. 2005; 116: e295-e302.
11. Lewis DW, Kellstein D, Dahl G, et al. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002; 42: 780-786.
12. Pakalnis A,. Current therapies in childhood and adolescent migraine. J Child Neurol. 2007; 22: 1288-1292.
13. Hardman JG, Gilman AG, Limbird LE, eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics, 9th edn. New York, NY: McGraw-Hill, Health Professions Division; 1996: 26.
14. Pozzi A, Gallelli L,. Pain management for dentists: The role of ibuprofen. Annali Di Stomatologia. 2011; II (Suppl. 3-4): 3-24.
15. Oliva F, Gallelli L,. Ibuprofen pharmacology and its implications for musculoskeletal disorders. Funct Neurol. 2010; 25 (Suppl. 1): 1-19.
16. Cissold SP,. Paracetamol and phenacetin. Drugs. 1986; 32: 46-59.
17. Anderson BJ,. Paracetamol (Acetaminophen): Mechanisms of action. Paediatr Anaesth. 2008; 18: 915-921.
18. De Fazio S, Gallelli L, Gareri P, Mazzotta D, Rende P, De Sarro G,. Pharmacological properties of nonsteroidal anti-inflammatory drugs: A review. Curr Top Pharmacol. 2009; 13: 75-83.
19. Grazzi L, Andrasik F, Usai S, Bussone G,. Magnesium as a preventive treatment for paediatric episodic tension-type headache: Results at 1-year follow-up. Neurol Sci. 2007; 28: 148-150.
20. Mauskop A, Altura BM,. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5: 24-27.
21. Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ,. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: A randomized, double-blind, placebo-controlled trial. Headache. 2003; 43: 601-610.
22. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004; 24: 1-152.
23. Bellieni CV, Cordelli DM, Raffaelli M, Ricci B, Morgese G, Buonocore G,. Analgesic effect of watching TV during venipuncture. Arch Dis Child. 2006; 91: 1015-1017.
24. Tomlinson D, Ethier M-C, Judd P, et al. Reliability and construct validity of the oral mucositis daily questionnaire in children with cancer. Eur J Cancer. 2011; 47: 383-388.
25. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30: 239-245.
26. Bianchi M, Broggini M, Balzarini P, Franchi S, Sacerdote P,. Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: Comparison with celecoxib. Int J Clin Pract. 2007; 61: 1270-1277.
27. De Fazio S, Gallelli L, De Siena A, De Sarro G, Scordo MG,. Role of CYP3A5 in abnormal clearance of methadone. Ann Pharmacother. 2008; 42: 893-897.
28. Gallelli L, Galasso O, Urzino A, et al. Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis. Clin Drug Invest. 2012; 32: 827-833.
29. Gallelli L, Colosimo M, Tolotta GA, et al. Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol. 2010; 66: 137-144.
30. Esposito M, Ruberto M, Pascotto A, Carotenuto M,. Nutraceutical preparations in childhood migraine prophylaxis: Effects on headache outcomes including disability and behaviour. Neurol Sci. 2012; 33: 1365-1368.
31. Silberstein SD,. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review). Neurology. 2000; 55: 754-762.
32. Kabbouche MA, Linder SL,. Acute treatment of pediatric headache in the emergency department and inpatient settings. Pediatr Ann. 2005; 34: 466-471.
33. Kan L, Nagelberg J, Maytal J,. Headaches in a pediatric emergency department: Etiology, imaging, and treatment. Headache. 2000; 40: 25-29.
34. Lewis DW, Qureshi F,. Acute headache in children and adolescents presenting to the emergency department. Headache. 2000; 40: 200-203.
35. Esposito M, Verrotti A, Gimigliano F, et al. Motor coordination impairment and migraine in children: A new comorbidity? Eur J Pediatr. 2012; 171: 1599-1604.
36. Fenichel GM,. Headache. In:, Fenichel GM, ed. Clinical Pediatric Neurology, 5th edn. Philadelphia, PA: Elsevier Saunders; 2005: 77-89.
37. Termine C, Ozge A, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C,. Overview of diagnosis and management of paediatric headache. Part II: Therapeutic management. J Headache Pain. 2011; 12: 25-34.
38. Hamalainen ML, Hoppu K, Valkeila E, Santavuori P,. Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997; 48: 103-107.
39. Lewis DW,. Children's ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002; 42: 780-786.
40. Suthisisang C, Poolsup N, Kittikulsuth W, Pudchakan P, Wiwatpanich P,. Efficacy of low-dose ibuprofen in acute migraine treatment: Systematic review and meta-analysis. Ann Pharmacother. 2007; 41: 1782-1791.
41. Codispoti JR, Prior MJ, Fu M, Nelson EB,. Efficacy of nonprescription doses of ibuprofen for treating migraine headache. A randomized controlled trial. Headache. 2001; 41: 665-679.
42. Goadsby PJ, Edvinsson L, Ekman R,. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990; 28: 183-187.
43. Bagdy G, Riba P, Kecskeméti V, Chase D, Juhász G,. Headache-type adverse effects of NO donors: Vasodilation and beyond. Br J Pharmacol. 2010; 160: 20-35.
44. Sun-Edelstein C, Mauskop A,. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009; 9: 369-379.
45. Soave PM, Conti G, Costa R, Arcangeli A,. Magnesium and anaesthesia. Curr Drug Targets. 2009; 10: 734-743.
46. Snyder SH,. Opiate receptors and beyond: 30 years of neural signaling research. Neuropharmacology. 2004; 47: 274-285.
47. Summ O, Andreou AP, Akerman S, Goadsby PJ,. A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: Relevance to indomethacin-sensitive headaches. J Headache Pain. 2010; 11: 477-483.
48. Gallelli L, Ferraro M, Mauro GF, De Fazio S, De Sarro G,. Nimesulide-induced hepatotoxicity in a previously healthy woman. Clin Drug Investig. 2005; 25: 421-424.
49. Gallelli L, Colosimo M, Pirritano D, Ferraro M, De Fazio S, De Sarro G,. Retrospective evaluation of adverse drug reactions induced by nonsteroidal anti-inflammatory drugs. Clin Drug Invest. 2007; 27: 115-122.
50. Scicchitano F, Giofrè C, Palleria C, et al. Pharmacovigilanze and drug safety in Calabria (Italy): Adverse events analysis. JRMS. 2012; 50: 872-875.